Bayer's Weinand On Pricing, Payers And Pipelines

 
• By Kevin Grogan
Deiter Weinand
Bayer's Pharma Chief Dieter Weinand implores broader value recognition for innovative medicines • Source: Bayer AG

More from Drug Pricing

More from Scrip